{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:05:32Z","timestamp":1774566332946,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,17]]},"DOI":"10.7759\/cureus.101739","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:57:09Z","timestamp":1768665429000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Portal Vein Thrombosis Associated With Anastrozole Therapy: A Report of a Rare Case"],"prefix":"10.7759","author":[{"given":"Rim A","family":"Boutari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perla E","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea S","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed AlRaouf","family":"Kawtharani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo N","family":"Naffah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Abou Rached","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1642-0990","article-title":"Portal vein thrombosis: diagnosis and endovascular management","volume":"194","author":"Ju C","year":"2022","unstructured":"Ju C, Li X, Gadani S, Kapoor B, Partovi S. Portal vein thrombosis: diagnosis and endovascular management. Rofo. 2022, 194:169-80. 10.1055\/a-1642-0990","journal-title":"Rofo"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/823063","article-title":"Portal vein thrombosis","volume":"2015","author":"Cohen R","year":"2015","unstructured":"Cohen R, Mallet T, Gale M, Soltys R, Loarte P. Portal vein thrombosis. Case Rep Vasc Med. 2015, 2015:823063. 10.1155\/2015\/823063","journal-title":"Case Rep Vasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp JF","year":"2013","unstructured":"Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013, 122:1712-23. 10.1182\/blood-2013-04-460121","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2009.01.001","article-title":"Thrombosis associated with angiogenesis inhibitors","volume":"22","author":"Elice F","year":"2009","unstructured":"Elice F, Rodeghiero F, Falanga A, Rickles FR. Thrombosis associated with angiogenesis inhibitors. Best Pract Res Clin Haematol. 2009, 22:115-28. 10.1016\/j.beha.2009.01.001","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2223955","article-title":"Investigating the risk of deep vein thrombosis with JAK inhibitors: a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS)","volume":"22","author":"Mytheen S","year":"2023","unstructured":"Mytheen S, Varghese A, Joy J, Shaji A, Tom AA. Investigating the risk of deep vein thrombosis with JAK inhibitors: a disproportionality analysis using FDA Adverse Event Reporting System Database (FAERS). Expert Opin Drug Saf. 2023, 22:985-94. 10.1080\/14740338.2023.2223955","journal-title":"Expert Opin Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1076029616683802","article-title":"Oral contraceptives and HRT risk of thrombosis","volume":"24","author":"Gialeraki A","year":"2018","unstructured":"Gialeraki A, Valsami S, Pittaras T, Panayiotakopoulos G, Politou M. Oral contraceptives and HRT risk of thrombosis. Clin Appl Thromb Hemost. 2018, 24:217-25. 10.1177\/1076029616683802","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-13585-0","article-title":"Real-world assessment of thromboembolic risk associated with tamoxifen","volume":"15","author":"Jia J","year":"2025","unstructured":"Jia J, Tian C, Han W, Ma Q. Real-world assessment of thromboembolic risk associated with tamoxifen. Sci Rep. 2025, 15:27820. 10.1038\/s41598-025-13585-0","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-05086-8","article-title":"Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors","volume":"174","author":"Xu X","year":"2019","unstructured":"Xu X, Chlebowski RT, Shi J, Barac A, Haque R. Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors. Breast Cancer Res Treat. 2019, 174:785-94. 10.1007\/s10549-018-05086-8","journal-title":"Breast Cancer Res Treat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-024-00227-z","article-title":"Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time","volume":"10","author":"Shaaban A","year":"2024","unstructured":"Shaaban A, Petersen A, Beckwith H, et al.. Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time. Cardiooncology. 2024, 10:27. 10.1186\/s40959-024-00227-z","journal-title":"Cardiooncology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/aimcc.2024.0296","article-title":"Concurrent arterial and venous thromboembolism while receiving an aromatase inhibitor","volume":"3","author":"Shahid I","year":"2024","unstructured":"Shahid I, Lee J, Jamriska S, et al.. Concurrent arterial and venous thromboembolism while receiving an aromatase inhibitor. Ann Intern Med Clin Cases. 2024, 3:240296. 10.7326\/aimcc.2024.0296","journal-title":"Ann Intern Med Clin Cases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2023.06.001","article-title":"Venous thromboembolism and breast cancer [Article in French]","volume":"110","author":"Crichi B","year":"2023","unstructured":"Crichi B, Moati E, Cacciatore C, Farge D, Frere C. Venous thromboembolism and breast cancer [Article in French]. Bull Cancer. 2023, 110:1051-62. 10.1016\/j.bulcan.2023.06.001","journal-title":"Bull Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2008.12.001","article-title":"Epidemiology of cancer-related venous thromboembolism","volume":"22","author":"Wun T","year":"2009","unstructured":"Wun T, White RH. Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol. 2009, 22:9-23. 10.1016\/j.beha.2008.12.001","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0054-6","article-title":"Drug-induced thrombosis: an update","volume":"36","author":"Ramot Y","year":"2013","unstructured":"Ramot Y, Nyska A, Spectre G. Drug-induced thrombosis: an update. Drug Saf. 2013, 36:585-603. 10.1007\/s40264-013-0054-6","journal-title":"Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0828-5","article-title":"Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer","volume":"13","author":"Yamamoto Y","year":"2008","unstructured":"Yamamoto Y, Iwase H. Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer. Int J Clin Oncol. 2008, 13:384-94. 10.1007\/s10147-008-0828-5","journal-title":"Int J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30020142","article-title":"Risk of cardiovascular events and lipid profile change in patients with breast cancer taking aromatase inhibitor: a systematic review and meta-analysis","volume":"30","author":"Yoo JJ","year":"2023","unstructured":"Yoo JJ, Jung EA, Kim Z, Kim BY. Risk of cardiovascular events and lipid profile change in patients with breast cancer taking aromatase inhibitor: a systematic review and meta-analysis. Curr Oncol. 2023, 30:1831-43. 10.3390\/curroncol30020142","journal-title":"Curr Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/446746-acute-portal-vein-thrombosis-associated-with-anastrozole-therapy-a-report-of-a-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T15:57:10Z","timestamp":1768665430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/446746-acute-portal-vein-thrombosis-associated-with-anastrozole-therapy-a-report-of-a-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.101739","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,17]]}}}